invivodata combines behavioural science, information technology and
clinical expertise to capture the highest-quality electronic Patient
Reported Outcome (ePRO) data in clinical research.
The invivodata solution, which includes DiaryPRO for real-time PRO data
collection and SitePRO(TM) for site-based PRO data collection, is based on
patented compliance methods that include a proven patient management system
that gives researchers and sponsors visibility into study progress and
improves trial efficiencies.
Strengthened by its regulatory and scientific expertise, invivodata is
the industry-leading eDiary provider for delivering primary efficacy data
for FDA approvals. Its solutions have been used in 140 clinical trials
worldwide by more than 55,000 patients, collecting over 89 million
patient-initiated entries for studies in over 65 disease states.
invivodata's scalable business model enables it to satisfy diverse client
needs and meet the increasing global demand for its innovative solutions.
invivodata inc. is a privately held company with global headquarters in
Pittsburgh, Pa., USA; its European headquarters are in London, England; and
its technology development centre is in Scotts Valley, Calif., USA.